Sotera Health (NYSE:SHC) Rating Increased to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Sotera Health (NYSE:SHC) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports.

According to Zacks, “Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. “

Shares of NYSE:SHC opened at $21.76 on Wednesday. The firm has a market cap of $6.16 billion, a price-to-earnings ratio of 181.35 and a beta of 0.18. Sotera Health has a 12 month low of $20.48 and a 12 month high of $30.38. The company’s fifty day simple moving average is $22.54 and its 200 day simple moving average is $23.93. The company has a quick ratio of 2.24, a current ratio of 2.52 and a debt-to-equity ratio of 3.39.

Sotera Health (NYSE:SHC) last released its earnings results on Wednesday, November 10th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.19 by $0.02. The firm had revenue of $226.16 million during the quarter, compared to analysts’ expectations of $222.55 million. Sotera Health had a return on equity of 35.74% and a net margin of 4.10%. Research analysts expect that Sotera Health will post 0.83 earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Spire Wealth Management lifted its position in shares of Sotera Health by 50.0% in the fourth quarter. Spire Wealth Management now owns 1,679 shares of the company’s stock worth $40,000 after purchasing an additional 560 shares in the last quarter. LGT Capital Partners LTD. increased its stake in Sotera Health by 9.0% in the 4th quarter. LGT Capital Partners LTD. now owns 365,000 shares of the company’s stock valued at $8,596,000 after buying an additional 30,000 shares during the last quarter. Vaughan Nelson Investment Management L.P. lifted its position in Sotera Health by 9.1% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 2,380,666 shares of the company’s stock worth $56,065,000 after buying an additional 199,525 shares in the last quarter. Diversified Trust Co boosted its stake in shares of Sotera Health by 0.8% during the 4th quarter. Diversified Trust Co now owns 64,794 shares of the company’s stock worth $1,526,000 after buying an additional 534 shares during the last quarter. Finally, Crossmark Global Holdings Inc. acquired a new position in Sotera Health during the fourth quarter valued at approximately $302,000. Institutional investors own 86.43% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Featured Story: Market Timing

Get a free copy of the Zacks research report on Sotera Health (SHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.